Learn About Latest Petition To Reschedule Magic Mushrooms In The UK

A new public appeal, launched just days ago, aims at moving psilocybin from Schedule 1 to Schedule 2 of UK’s Misuse of Drugs 2001 legislation. As all regulations, it determines the legal circumstances for possession, supply, production, export and import of the listed (so called “controlled”) drugs. The authorized scope depends on the assigned schedule, ranging […]
Pfizer, Global Blood Therapeutics In Advanced Talks For $5B Buyout Deal: Report

Pfizer Inc (NYSE: PFE) is reportedly in advanced talks to buy Global Blood Therapeutics Inc (NASDAQ: GBT) for about $5 billion, bolster its portfolio and pipeline. Global Blood Therapeutics markets sickle-cell disease treatment, Oxbryta, which generated $194.7 million in revenue in 2021. Read More
India Based Pharma Companies In Race To Buy Athenex, Shares Surge

Athenex Inc (NASDAQ: ATNX) shares climbed during the after-hours session as India’s Intas Pharmaceuticals and Dr Reddy’s Laboratories Ltd (NYSE: RDY) are reportedly in talks to acquire Athenex. According to the Economic Times report, the deal could be valued at $200-250 million as the U.S.-based biotechnology firm looks to sell a controlling stake. The two Indian pharma companies are competing with […]
CBOE’s Weekly Market Recap: July 18 To 22

Following last week’s price movements on the SPDR S&P 500 ETF Trust (NYSEARCA: SPY), it appears that July may be the first month to close with a price ascension of over 1% since March. While macroeconomic data seems to suggest that the American economy is still in a recession, several indices show price ascension that […]
Will This Cannabis Company Also Become A Psilocybin Producer And Facilitator? Here’s What They’re Thinking

Kaya Holdings Inc., (OTCQB: KAYS), also known as “KAYS,” holder and operator of U.S cannabis licenses in all plant-touching categories, initiated the process of seeking the requisite licenses to manufacture psilocybin and set up facilitation service centers in Oregon. As a reminder, the state was the first to legalize the use of psychedelics for mental health treatments in […]
Which Broker/Investment Bank Could Be Purchased Next, Following $1.3B Cowen/TD Deal?

The latest bank/investment firm M&A came on Tuesday as Toronto-Dominion Bank (NYSE: TD) bought Cowen Inc (NASDAQ: COWN) in an all cash deal valued at $1.3 billion or $39 per share, according to a TD Bank Group press release. TD believes that “through this transaction, TD Securities will accelerate its long-term growth strategy in the United […]
After Alpha: How Can Traders Gain An Edge? Cyclical Systems Like This One Could Provide An Answer

Markets can be highly volatile, which is glaringly obvious in the world of cryptocurrency. The crypto market and the individual assets that comprise it are subject to extreme swings in value. While this can make things difficult, it also theoretically creates opportunities for smart traders who are able to properly strategize on the direction of […]
Pinterest To Report Earnings After Today’s Closing Bell: Here’s What To Look For

Social media giant Pinterest Inc (NYSE: PINS) will report its second-quarter earnings after market close today (Aug. 1). Earnings Outlook: Analysts are expecting steady growth from the first quarter of 2022, with an estimated growth in both revenue and earnings per share. Consensus analyst estimates are expecting revenues of $666.57 million and earnings per share (EPS) of $0.18. […]
Psychedelics For Active Military Personnel: Democrat And Republican-backed Bills Being Considered

House Reps. Alexandria Ocasio-Cortez (D-N.Y.) and Dan Crenshaw (R-Texas) have recently filed separate bills towards further advancing psychedelic research studies to active service members. While it was AOC’s proposal which was finally made in order in the House Rules Committee for the 2023 National Defense Authorization Act (NDAA), its fate is still unclear. Nonetheless, several key […]
Biden Administration Agrees On The Need For A Task Force To Advance Psychedelics Research

A letter on behalf of the federal Health and Human Services (HHS) department acknowledges that the ongoing mental health and substance use crises require for the potential of psychedelic-assisted therapies to be further explored. The department would establish a task-force to do so, first reported by Mattha Busby in The Intercept. The document, written in May 2022 and […]